塔克罗利木斯和质子抑制剂在接受脏移植的接受者的相互作用
Khouloud Ferchichi1, Syrine Ben Hammamia, Mouna Ben Sassi
1From the Department of Clinical Pharmacology, National Centre Chalbi Belkahia of Pharmacovigilance, Tunis, Tunisia and the Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
概括
像奥梅普拉这样的质子抑制剂可以增加移植患者的塔克罗利水平,可能导致毒性. 当同时服用这些药物时,密切监测塔克罗利斯药物水平至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植 移植 移植 移植
背景情况:
- 塔克罗利斯是移植后的主要免疫抑制剂.
- 质子抑制剂 (PPI) 通常用于胃肠道保护.
- 塔克罗利斯和PPI之间的药物相互作用需要仔细考虑.
研究的目的:
- 为了记录与质子抑制剂联合使用的塔克罗利斯的药物监测概况.
- 为了研究梅对塔克罗利斯血清最低水平的影响,在接受脏移植的接受者.
主要方法:
- 一个23岁的男性移植患者的病例报告.
- 在开始服用奥梅普拉之前和之后监测塔克罗利莫斯的血清最低水平.
- 评估与塔克罗利斯水平相关的功能.
主要成果:
- 在开始服用奥梅普拉 (每天20毫克) 后,塔克罗利斯水平显著增加.
- 观察到29.5 ng/mL的峰值水平,需要减少塔克罗利斯剂量.
- 奥梅普拉撤销使塔克罗利斯水平正常化,这表明药物相互作用.
结论:
- 奥梅普拉可以显著增加塔克罗利马斯的血清水平.
- 这种相互作用可能导致功能改变和潜在的毒性.
- 严密的治疗药物监测的塔克罗利斯是必要的,当与奥梅普拉同时使用.
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Renal Drug Excretion: Tubular Secretion
183
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
183
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
431
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
431
Renal Drug Excretion: Tubular Reabsorption
172
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
172


